Shuai Qie Lanhui Yuan Hong-Yun Shi Xi Zhang Yanhong Li
10.1097/MD.0000000000013869
Medicine (Baltimore)
2019 Jan;98(1):e13869.
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/30608405/
Antineoplastic Agents, Alkylating / therapeutic use Brain Neoplasms / therapy Glioblastoma / therapy Radiosurgery / methods Temozolomide / therapeutic use
Antineoplastic Agents, Alkylating / therapeutic use Brain Neoplasms / therapy Glioblastoma / therapy Radiosurgery / methods Temozolomide / therapeutic use Case Reports Adult Combined Modality Therapy Female Humans Neoplasm Grading Neoplasm Recurrence, Local Radiation Dosage Reoperation / methods Antineoplastic Agents, Alkylating Temozolomide
PMC6344191
30608405
Conventionally fractionated stereotactic radiotherapy (CFRT) in combination with dose-dense temozolomide (TMZ) in relapsed malignant glioma: A case report
2019